‌

US Patent 11760728 Tead inhibitors and uses thereof

Patent 11760728 was granted and assigned to Ikena Oncology on September, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent attributes

Patent Applicant

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Alfredo C. Castro

Date of Patent

September 19, 2023

Patent Application Number

17646787

Date Filed

January 3, 2022

Patent Citations

US Patent 7582643 Heterocyclic compounds useful in treating diseases and conditions

US Patent 7750158 Cannabinoid receptor ligands

US Patent 7902373 Nicotinamide derivatives

US Patent 7932246 Histone deacetylase inhibitors

US Patent 7935725 Aryl-substituted bridged or fused diamines as modulators of leukotriene A

US Patent 8022221 Aurora kinase modulators and method of use

US Patent 8067589 Heterocyclic compounds useful in treating diseases and conditions

US Patent 8124639 Bicyclic [3.1.0] heteroaryl amides as type 1 glycine transport inhibitors

...

Patent Citations Received

US Patent 11925651 TEAD inhibitors and uses thereof

0

Patent Primary Examiner

Shawquia Jackson

CPC Code

Patent abstract

The present invention provides compounds, compositions thereof, and methods of using the same.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11760728 Tead inhibitors and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.